Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-03-01 Purchase | 2022-03-01 5:58 pm | Regulus Therapeutics Inc. | RGLS | Drygin Denis Chief Scientific Officer | 76,686 | $0.23 | $17,638 | 100,000 (Direct) | View |
| 2022-02-04 Purchase | 2022-02-07 5:09 pm | Regulus Therapeutics Inc. | RGLS | Drygin Denis Chief Scientific Officer | 23,314 | $0.23 | $5,362 | 23,314 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-01-12 Option Award | 2022-01-26 4:14 pm | N/A 2032-01-11 | Regulus Therapeutics Inc. | RGLS | Drygin Denis Chief Scientific Officer | 400,000 | $0 | 400,000 (Direct) | View |
| 2021-02-04 Option Award | 2021-02-05 5:00 pm | N/A 2031-02-04 | Regulus Therapeutics Inc. | RGLS | Drygin Denis Chief Scientific Officer | 120,000 | $0 | 120,000 (Direct) | View |
| 2020-03-03 Option Award | 2020-08-05 09:12 am | N/A 2030-08-02 | Regulus Therapeutics Inc. | RGLS | Drygin Denis Chief Scientific Officer | 300,000 | $0 | 300,000 (Direct) | View |